Cargando…
Advances in Development and Application of Influenza Vaccines
Influenza A virus is one of the most important zoonotic pathogens that can cause severe symptoms and has the potential to cause high number of deaths and great economic loss. Vaccination is still the best option to prevent influenza virus infection. Different types of influenza vaccines, including l...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313855/ https://www.ncbi.nlm.nih.gov/pubmed/34326849 http://dx.doi.org/10.3389/fimmu.2021.711997 |
_version_ | 1783729430553690112 |
---|---|
author | Chen, Jidang Wang, Jiehuang Zhang, Jipei Ly, Hinh |
author_facet | Chen, Jidang Wang, Jiehuang Zhang, Jipei Ly, Hinh |
author_sort | Chen, Jidang |
collection | PubMed |
description | Influenza A virus is one of the most important zoonotic pathogens that can cause severe symptoms and has the potential to cause high number of deaths and great economic loss. Vaccination is still the best option to prevent influenza virus infection. Different types of influenza vaccines, including live attenuated virus vaccines, inactivated whole virus vaccines, virosome vaccines, split-virion vaccines and subunit vaccines have been developed. However, they have several limitations, such as the relatively high manufacturing cost and long production time, moderate efficacy of some of the vaccines in certain populations, and lack of cross-reactivity. These are some of the problems that need to be solved. Here, we summarized recent advances in the development and application of different types of influenza vaccines, including the recent development of viral vectored influenza vaccines. We also described the construction of other vaccines that are based on recombinant influenza viruses as viral vectors. Information provided in this review article might lead to the development of safe and highly effective novel influenza vaccines. |
format | Online Article Text |
id | pubmed-8313855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83138552021-07-28 Advances in Development and Application of Influenza Vaccines Chen, Jidang Wang, Jiehuang Zhang, Jipei Ly, Hinh Front Immunol Immunology Influenza A virus is one of the most important zoonotic pathogens that can cause severe symptoms and has the potential to cause high number of deaths and great economic loss. Vaccination is still the best option to prevent influenza virus infection. Different types of influenza vaccines, including live attenuated virus vaccines, inactivated whole virus vaccines, virosome vaccines, split-virion vaccines and subunit vaccines have been developed. However, they have several limitations, such as the relatively high manufacturing cost and long production time, moderate efficacy of some of the vaccines in certain populations, and lack of cross-reactivity. These are some of the problems that need to be solved. Here, we summarized recent advances in the development and application of different types of influenza vaccines, including the recent development of viral vectored influenza vaccines. We also described the construction of other vaccines that are based on recombinant influenza viruses as viral vectors. Information provided in this review article might lead to the development of safe and highly effective novel influenza vaccines. Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8313855/ /pubmed/34326849 http://dx.doi.org/10.3389/fimmu.2021.711997 Text en Copyright © 2021 Chen, Wang, Zhang and Ly https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Chen, Jidang Wang, Jiehuang Zhang, Jipei Ly, Hinh Advances in Development and Application of Influenza Vaccines |
title | Advances in Development and Application of Influenza Vaccines |
title_full | Advances in Development and Application of Influenza Vaccines |
title_fullStr | Advances in Development and Application of Influenza Vaccines |
title_full_unstemmed | Advances in Development and Application of Influenza Vaccines |
title_short | Advances in Development and Application of Influenza Vaccines |
title_sort | advances in development and application of influenza vaccines |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313855/ https://www.ncbi.nlm.nih.gov/pubmed/34326849 http://dx.doi.org/10.3389/fimmu.2021.711997 |
work_keys_str_mv | AT chenjidang advancesindevelopmentandapplicationofinfluenzavaccines AT wangjiehuang advancesindevelopmentandapplicationofinfluenzavaccines AT zhangjipei advancesindevelopmentandapplicationofinfluenzavaccines AT lyhinh advancesindevelopmentandapplicationofinfluenzavaccines |